Abstract:Glioblastoma (GBM) is the most common malignant primary tumor in the human central nervous system. The present study aimed to explore the molecular mechanism by which microRNA (miR)-181a-5p targets the F-box protein 11 (FBXO11) in glioma cells to inhibit cell proliferation and invasion. Reverse transcription-quantitative (RT-q)PCR was performed to detect the expression levels of miR-181a-5p in U251TR cells, U251 cells, primary GBM tissues and relapsed GBM tissues in order to determine the association between miR-181a-5p and the chemoresistance of GBM cells. The expression levels of miR-181a-5p in GBM cells were modulated via transfecting miR-181a-5p mimics and inhibitors. Cell Counting Kit-8 assays were undertaken to assess the effects of miR-181a-5p on drug sensitivity and proliferation of GBM cells. Wound healing assays were performed to examine the effects of miR-181a-5p on the migratory ability of GBM cells. Furthermore, the effects of miR-181a-5p on the invasive ability of GBM cells were analyzed using an in vitro invasion assay. Flow cytometry analysis was carried out to determine whether overexpression of miR-181a-5p can promote the apoptotic rate of GBM cells. RT-qPCR and western blotting were employed to detect the effects of miR-181a-5p on mRNA and protein expression of FBX011. miR-181a-5p exhibited low expression in resistant GBM cell lines and recurrent tumor tissues. Dual-luciferase reporter assays were utilized to detect luciferase activity to verify the targeted regulatory association between miR-181a-5p and FBXO11. Upregulation of miR-181a-5p promoted the sensitivity of GBM cells to temozolomide (TMZ), increased the apoptotic rate of GBM cells and significantly inhibited the invasive and migratory capacities of GBM cells. In drug-resistant glioma cells, compared with the miR-negative control group and the blank group, the expression of miR-181a-5p was significantly upregulated (P<0.01), while the expression of FBXO11 protein was downregulated. miR-181a-5p increased the sensitivity of GBM cells to TMZ. miR-181a-5p significantly inhibited the migratory and invasive capacities of GBM cells. miR-181a-5p may become a novel effective target for the treatment of GBM. The results of dual-luciferase reporter assays indicated that miR-181a-5p could target the 3'-untranslated region of FBXO11. The underlying mechanism may be targeted inhibition of FBXO11 gene expression, or may be associated with apoptosis.

miR-181b Expression in Human Gliomas and Its Clinical Significance

miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.

Upregulation of Mir-183 Expression and Its Clinical Significance in Human Brain Glioma

The Relationship between Expression of the miR-181 Family and Malignancy of Human Glioma

miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1

MiR-181b Suppresses Proliferation of and Reduces Chemoresistance to Temozolomide in U87 Glioma Stem Cells

MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2

Downregulation of Mir-154 in Human Glioma and Its Clinicopathological and Prognostic Significance

MicroRNA-181 Inhibits Glioma Cell Proliferation by Targeting Cyclin B1.

Mir-182 As a Prognostic Marker for Glioma Progression and Patient Survival

MiR-301a is interrelated with poor prognosis and contributes to temozolomide resistance in human glioma

RETRACTED: Downregulation of Mir-204 Expression Correlates with Poor Clinical Outcome of Glioma Patients

Mir-181A-5p Inhibits the Proliferation and Invasion of Drug-Resistant Glioblastoma Cells by Targeting F-box Protein 11 Expression

Reduced Expression of Mir-3653 in Glioma and Its Correlations with Clinical Progression and Patient Survival

miR-19a and miR-19b Overexpression in Gliomas

Decreased Expression of Microrna-107 Predicts Poorer Prognosis in Glioma

Correlation of microRNA-10b upregulation and poor prognosis in human gliomas

Correlation of Microrna-375 Downregulation with Unfavorable Clinical Outcome of Patients with Glioma

Expression of Microrna-184 in Glioma

Decreased Expression of Mir-378 Correlates with Tumor Invasiveness and Poor Prognosis of Patients with Glioma.

MicroRNA-133b expression associates with clinicopathological features and prognosis in glioma.